Baird Financial Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Baird Financial Group’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,677	Closed	-$259K	–	1333
2017 Q4	$259K	Sell	5,677 -1,650	-23%	-$82.3K	﹤0.01%	1160
2017 Q3	$329K	Sell	7,327 -5,060	-41%	-$173K	﹤0.01%	1088
2017 Q2	$370K	Sell	12,387 -16,196	-57%	-$400K	﹤0.01%	1039
2017 Q1	$634K	Buy	28,583 +5,839	+26%	+$125K	0.01%	894
2016 Q4	$429K	Sell	22,744 -857	-4%	-$21K	﹤0.01%	961
2016 Q3	$708K	Buy	23,601 +11,134	+89%	+$346K	0.01%	844
2016 Q2	$359K	Buy	12,467 +4,587	+58%	+$190K	﹤0.01%	1007
2016 Q1	$300K	Buy	7,880 +3,185	+68%	+$111K	﹤0.01%	1052
2015 Q4	$206K	Sell	4,695 -1,080	-19%	-$53.6K	﹤0.01%	1159
2015 Q3	$235K	Buy	+5,775	New	+$253K	﹤0.01%	1117

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Baird Financial Group's JUNO Position: Q1 2018 in Review

Baird Financial Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 5,677 shares — an estimated $259K sold.

Baird Financial Group first reported a position in JUNO in Q3 2015 and held it in 10 quarters. The position peaked at $708K in Q3 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Baird Financial Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Baird Financial Group sold 5,677 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $259K.
Baird Financial Group first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 10 quarters.
Baird Financial Group's Juno Therapeutics, Inc. position peaked at $708K in Q3 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Baird Financial Group's 13F filing for Q1 2018, filed 14 May 2018.